Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Generic controlled-release carbamazepine approved in U.K.

April 27, 1998

OHM-3507: a fentanyl derivative with incongruent pharmacological effects

April 24, 1998

AChE inhibitors for Alzheimer's disease disclosed by Sagami

April 24, 1998

Positive phase III results reported for Neurobloc in cervical dystonia

April 24, 1998

Danaparoid sodium is not beneficial for acute ischemic stroke

April 24, 1998

Toray analgesic in clinical development worldwide

April 23, 1998

Suntory researchers discover new treatments for convulsions, ischemia

April 23, 1998

AIT-082 enhances memory function in preclinical model

April 23, 1998

Sepracor receives U.S. patent protection for single-isomer SSRI

April 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...